Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Granotapide
Cat. No.:
0225LY-1234
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Granotapide is a microsomal triglyceride transfer protein (MTP) inhibitor utilized for the prevention and treatment of metabolic syndrome, coronary artery disease, and hypertension.
Synonym:
594842-13-4; Diethyl 2-((3-dimethylcarbamoyl-4-((4'-trifluoromethylbiphenyl-2-carbonyl)amino)phenyl)acetyloxymethyl)-2-phenylmalonate; Diethyl 2-[[2-[3-(dimethylcarbamoyl)-4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]phenyl]acetyl]oxymethyl]-2-phenylpropanedioate; Diethyl 2-({2-[3-(dimethylcarbamoyl)-4-{4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamido}phenyl]acetyloxy}methyl)-2-phenylpropanedioate; Diethyl 2-((2-(3-(dimethylcarbamoyl)-4-(4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamido)phenyl)acetoxy)methyl)-2-phenylmalonate
CAS No.:
594842-13-4
Compound CID:
11607299
Formula:
C39H37F3N2O8
Formula Weight:
718.71
Specification
Relative Density:
1.285 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Granotapide can be used in lipid research to examine the inhibition of microsomal triglyceride transfer protein (MTP).
Library Information
Target:
MTP
Receptor:
MTTP
Pathways:
Metabolism
Plate Number:
AOCL-16
Plate Location:
g11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
27.5 mg/mL; 38.26 mM
